Hemoglobin dan Adekuasi Berkorelasi dengan Kualitas Hidup dan Kinerja Jantung Pada Pasien Hemodialisis
Abstract
Pendahuluan. Penyait Ginjal Stadium Akhir (end stage renal disease, ESRD) merupakan stadium Penyakit Ginjal Kronis (PGK) yang memerlukan terapi pengganti ginjal termasuk hemodialisis (HD). Indikator keberhasilan HD termasuk kinerja jantung dan kualitas hidup pasien diyakini tergantung pada indikator proses yang meliputi kecukupan (adekuasi) HD, kejadian anemia serta malfungsi akses vaskular dan infeksi.
Tujuan. Penelitian ini bertujuan untuk menilai hubungan antara indikator proses dan indikator hasil pasien HD.
Metode. Penelitian ini merupakan penelitian observasional analitik dengan pendekatan kohort yang melibatkan 350 pasien dari 5 unit HD di Provinsi Aceh. Data diperoleh dari rekam medis pasien, sedangkan kualitas hidup pasien HD dinilai dengan kuesioner Kidney Disease Quality of Life (KDQoL). Kinerja jantung dinilai dengan menggunakan ekokardiografi.
Hasil. Hasil penelitian menunjukkan adanya hubungan positif yang signifikan antara hemoglobin (Hb) dan adekuasi HD dengan fraksi ejeksi pasien yang menjalani HD. Selain itu, penelitian ini juga menemukan hubungan positif yang signifikan antara Hb dan adekuasi dengan kualitas hidup pasien HD, terutama fungsi fisik dan kesejahteraan emosional.
Kesimpulan. Adanya korelasi positif antara Hb dan adekuasi HD dengan kinerja jantung dan kualitas hidup menunjukkan pentingnya indikator proses dalam meningkatkan kualitas pelayanan HD serta pasien HD.
Keywords
References
Couser WG, Remuzzi G, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney International [Internet]. 2011;80(12):1258–70. Available from: http://dx.doi.org/10.1038/ki.2011.368
Suwitra K. Penyakit Ginjal Kronik. In: Buku Ajar Ilmu Penyakit Dalam Edisi VI. VI. Jakarta: Interna Publishing; 2015. p. 2159–65.
Hakim RM. Hemodialysis. In: Gilbert SJ, Weiner DE, editors. National Kidney Foundation’s Primer on Kidney Disease. 6th ed. Philadelphia: Elsevier Saunders; 2014. p. 508–19.
Kidney Disease Improving Global Outcomes. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International [Internet]. 2013 Jan;3(1):1–150. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0085253815560067
Bieber SD, Himmelfarb J. Haemodialysis: prescription and assessment of adequacy. In: Turner N, Lameire N, Goldsmith DJ, Winearls CG, Himmelfarb J, Remuzzi G, editors. Oxford Textbook of Clinical Nephrology. 4th ed. Oxford: Oxford University Press; 2016. p. 2199–217.
Toussaint ND, McMahon LP, Dowling G, Soding J, Safe M, Knight R, et al. Implementation of renal key performance indicators: Promoting improved clinical practice. Nephrology. 2015;20(3):184–93.
Toussaint ND, McMahon LP, Dowling G, Holt SG, Smith G, Safe M, et al. Introduction of renal key performance indicators associated with increased uptake of peritoneal dialysis in a publicly funded health service. Peritoneal Dialysis International. 2017;37(2):198–204.
Pongpirul K, Kanjanabuch T, Puapatanakul P, Chuengsaman P, Dandecha P, Kingwatanakul P, et al. National feasibility survey of peritoneal dialysis key performance indicators in Thailand from provider perspective. Nephrology. 2020;25(6):483–90.
Cohen DE, Lee A, Sibbel S, Benner D, Brunelli SM, Tentori F. Use of the KDQOL-36TM for assessment of health-related quality of life among dialysis patients in the United States. BMC Nephrology [Internet]. 2019;20(1):112. Available from: https://doi.org/10.1186/s12882-019-1295-0
Supriyadi R, Rakhima F, Gondodiputro RS, Darmawan G. Validity and Reliability of the Indonesian Version of Kidney Disease Quality of Life (KDQOL-36) Questionnaire in Hemodialysis Patients at Hasan Sadikin Hospital, Bandung, Indonesia. Acta medica Indonesiana. 2019;51(4):318–23.
Victoria SC. Renal key performance indicators review. Melbourne: Victorian Government; 2019.
Eliakim-Raz N, Prokupetz A, Gordon B, Shochat T, Grossman A. Interventricular Septum and Posterior Wall Thickness Are Associated With Higher Systolic Blood Pressure. The Journal of Clinical Hypertension [Internet]. 2016 Jul 1;18(7):703–6. Available from: https://doi.org/10.1111/jch.12738
Duran M, Unal A, Inanc MT, Esin F, Yilmaz Y, Ornek E. Effect of maintenance hemodialysis on diastolic left ventricular function in end-stage renal disease. Clinics (Sao Paulo, Brazil) [Internet]. 2010;65(10):979–84. Available from: https://pubmed.ncbi.nlm.nih.gov/21120298
Chuang MK, Chang CH, Chan CY. The effect of haemodialysis access types on cardiac performance and morbidities in patients with symptomatic heart disease. PLoS ONE [Internet]. 2016;11(2):1–11. Available from: http://dx.doi.org/10.1371/journal.pone.0148278
Locatelli P, Olea FD, de Lorenzi A, Salmo F, Vera Janavel GL, Hnatiuk AP, et al. Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans. International journal of clinical and experimental medicine [Internet]. 2011/10/22. 2011;4(4):258–64. Available from: https://pubmed.ncbi.nlm.nih.gov/22140597
Bakkaloğlu SA, Kandur Y, Serdaroğlu E, Noyan A, Bayazıt AK, Taşdemir M, et al. Time-averaged hemoglobin values, not hemoglobin cycling, have an impact on outcomes in pediatric dialysis patients. Pediatric Nephrology. 2018;33(11):2143–50.
Sadeghi M, Ebrahimi H, Abbasi M, Norouzadeh R. Relationship between anemia, quality of life, and laboratory indices in hemodialysis patients. Saudi Journal of Kidney Diseases and Transplantation [Internet]. 2016 Sep 1;27(5):1063–7. Available from: https://www.sjkdt.org/article.asp?issn=1319-2442
Ebrahimi V, Khademian MH, Masoumi SJ, Morvaridi MR, Ezzatzadegan Jahromi S. Factors influencing survival time of hemodialysis patients; Time to event analysis using parametric models: A cohort study. BMC Nephrology. 2019;20(1):1–9.
Kuo KL, Hung SC, Tseng WC, Tsai MT, Liu JS, Lin MH, et al. Association of anemia and iron parameters with mortality among patients undergoing prevalent hemodialysis in Taiwan: The AIM-HD study. Journal of the American Heart Association. 2018;7(15).
Nishiwaki H, Hasegawa T, Koiwa F, Hamano T, Masakane I. The association of the difference in hemoglobin levels before and after hemodialysis with the risk of 1-year mortality in patients undergoing hemodialysis. Results from a nationwide cohort study of the Japanese Renal Data Registry. PLoS ONE. 2019;14(1):1–13.
Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, et al. Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction. Journal of the American College of Cardiology. 2001 Oct;38(4):955–62.
Assa S, Hummel YM, Voors AA, Kuipers J, Westerhuis R, de Jong PE, et al. Hemodialysis-induced regional left ventricular systolic dysfunction: prevalence, patient and dialysis treatment-related factors, and prognostic significance. Clinical journal of the American Society of Nephrology: CJASN. 2012 Oct;7(10):1615–23.
Momeni A, Khaledi A, Hasanzadeh K. Reduction of left ventricular ejection fraction after 12-month follow-up in hemodialysis patients. Journal of renal injury prevention [Internet]. 2016 Feb 24;5(1):8–11. Available from: https://pubmed.ncbi.nlm.nih.gov/27069961
Perkumpulan Nefrologi Indonesia. 11th Report of Indonesian Renal Registry 2018. Jakarta; 2018.
Hecking M, Bieber BA, Ethier J, Kautzky-Willer A, Sunder-Plassmann G, Säemann MD, et al. Sex-specific differences in hemodialysis prevalence and practices and the male-to-female mortality rate: the Dialysis Outcomes and Practice Patterns Study (DOPPS). PLoS medicine. 2014 Oct;11(10):e1001750.
Chang P-Y, Chien L-N, Lin Y-F, Wu M-S, Chiu W-T, Chiou H-Y. Risk factors of gender for renal progression in patients with early chronic kidney disease. Medicine. 2016 Jul;95(30):e4203.
Neugarten J, Golestaneh L. Gender and the prevalence and progression of renal disease. Advances in chronic kidney disease. 2013 Sep;20(5):390–5.
Précis: An introduction to end-stage renal disease in the U.S. American Journal of Kidney Diseases. 2014;63(1 SUPPL.):169–92.
Webster AC, Nagler E v, Morton RL, Masson P. Chronic Kidney Disease. The Lancet [Internet]. 2017 Mar;389(10075):1238–52. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0140673616320645
Bargman JM, Skorecki KL. Chronic Kidney Disease. In: Kasper M, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J, editors. Harrison’s Principles of Internal Medicine. 20th ed. New York, NY: McGraw-Hill Education; 2018. p. 2111–21.
Charles C, Ferris AH. Chronic Kidney Disease. Primary care [Internet]. 2020 Dec;47(4):585–95. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0095454320300555
Parikh S v., Almaani S, Brodsky S, Rovin BH. Update on Lupus Nephritis: Core Curriculum 2020. American Journal of Kidney Diseases [Internet]. 2020 Aug;76(2):265–81. Available from: https://linkinghub.elsevier.com/retrieve/pii/S0272638619311709
al Salmi I, Larkina M, Wang M, Subramanian L, Morgenstern H, Jacobson SH, et al. Missed Hemodialysis Treatments: International Variation, Predictors, and Outcomes in the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases. 2018 Nov;72(5):634–43.
Miller LM, Clark E, Dipchand C, Hiremath S, Kappel J, Kiaii M, et al. Hemodialysis Tunneled Catheter-Related Infections. Canadian journal of kidney health and disease. 2016 Sep 27;3:2054358116669129–2054358116669129.
Stolic R. Most Important Chronic Complications of Arteriovenous Fistulas for Hemodialysis. Medical Principles and Practice [Internet]. 2013;22(3):220–8. Available from: https://www.karger.com/DOI/10.1159/000343669
Juwita I. Hubungan Komposisi Tubuh dengan Protein Energy Wasting pada Pasien Hemodialisis Kronik. Universitas Syiah Kuala; 2020.
Ward RA. Heparinization for routine hemodialysis. Advances in renal replacement therapy. 1995 Oct;2(4):362–70.
Shen JI, Mitani AA, Chang TI, Winkelmayer WC. Use and safety of heparin-free maintenance hemodialysis in the USA. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association [Internet]. 2013/04/05. 2013 Jun;28(6):1589–602. Available from: https://pubmed.ncbi.nlm.nih.gov/23563280
Burton JO, Jefferies HJ, Selby NM, McIntyre CW. Hemodialysis-induced cardiac injury: determinants and associated outcomes. Clinical journal of the American Society of Nephrology : CJASN. 2009 May;4(5):914–20.
Ricardo AC, Hacker E, Lora CM, Ackerson L, DeSalvo KB, Go A, et al. Validation of the Kidney Disease Quality of Life Short Form 36 (KDQOL-36) US Spanish and English versions in a cohort of Hispanics with chronic kidney disease. Ethnicity & disease. 2013;23(2):202–9.
Anand IS, Gupta P. Anemia and Iron Deficiency in Heart Failure. Circulation. 2018 Jul 3;138(1):80–98.
Kuwahara M, Iimori S, Kuyama T, Akita W, Mori Y, Asai T, et al. Effect of anemia on cardiac disorders in pre-dialysis patients immediately before starting hemodialysis. Clinical and experimental nephrology. 2011 Feb;15(1):121–5.
Hamilton G, Locking-Cusolito H. Hemodialysis adequacy and quality of life: how do they relate? CANNT journal = Journal ACITN. 2003;13(4):24–9.
Manns BJ, Johnson JA, Taub K, Mortis G, Ghali WA, Donaldson C. Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO journal (American Society for Artificial Internal Organs : 1992). 2002;48(5):565–9.
DOI: 10.24815/jks.v22i1.24769
Refbacks
- There are currently no refbacks.